Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-07 Sale | 2024-03-11 8:31 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 10,162 | $66.21 | $672,791 | 27,148 (Direct) | View |
2024-02-26 Sale | 2024-02-27 7:58 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 4,112 | $70.17 | $288,534 | 9,488 (Direct) | View |
2024-02-02 Sale | 2024-02-05 6:02 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 6,167 | $67.19 | $414,355 | 5,693 (Direct) | View |
2024-01-02 Sale | 2024-01-04 7:54 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 62,282 | $70.6 | $4,397,113 | 0 (Direct) | View |
2023-12-13 Sale | 2023-12-15 5:01 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 21,262 | $65 | $1,382,030 | 0 (Direct) | View |
2023-07-17 Sale | 2023-07-20 5:47 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 1,842 | $65 | $119,730 | 21,262 (Direct) | View |
2023-03-13 Sale | 2023-03-13 7:36 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 7,344 | $45.04 | $330,794 | 37,794 (Direct) | View |
2023-02-24 Sale | 2023-02-27 8:02 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer | 7,906 | $47.14 | $372,689 | 31,011 (Direct) | View |
2023-02-21 Sale | 2023-02-22 8:04 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer | 8,354 | $46.84 | $391,304 | 23,104 (Direct) | View |
2022-03-02 Sale | 2022-03-04 6:05 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 8,037 | $56.28 | $452,313 | 23,104 (Direct) | View |
2022-02-24 Sale | 2022-02-25 7:09 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 4,046 | $52.27 | $211,468 | 46,954 (Direct) | View |
2022-02-22 Sale | 2022-02-23 7:08 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 4,177 | $55.29 | $230,958 | 35,635 (Direct) | View |
2022-01-18 Sale | 2022-01-20 4:07 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 6,223 | $42.03 | $261,553 | 23,104 (Direct) | View |
2022-01-10 Sale | 2022-01-11 8:08 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 6,870 | $40.76 | $280,020 | 29,327 (Direct) | View |
2021-02-19 Sale | 2021-02-22 8:09 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 2,734 | $39.25 | $107,310 | 39,812 (Direct) | View |
2021-01-11 Sale | 2021-01-12 7:07 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 4,367 | $32.12 | $140,259 | 30,577 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-10 Exercise | 2024-03-11 8:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 7,345 | $0 | 27,148 (Direct) | View |
2024-03-06 Exercise | 2024-03-08 5:58 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 13,132 | $0 | 48,886 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 7:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 26,227 | $0 | 26,227 (Direct) | View |
2024-02-23 Exercise | 2024-02-27 7:58 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 7,907 | $0 | 9,488 (Direct) | View |
2024-02-01 Option Award | 2024-02-05 6:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 11,860 | $0 | 5,693 (Direct) | View |
2024-01-02 Exercise | 2024-01-04 7:54 pm | N/A 2028-08-15 | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 62,282 | $0 | 0 (Direct) | View |
2024-01-02 Exercise | 2024-01-04 7:54 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 62,282 | $19.87 | 0 (Direct) | View |
2023-03-10 Exercise | 2023-03-13 7:36 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 7,344 | $0 | 37,794 (Direct) | View |
2023-03-06 Option Award | 2023-03-08 7:54 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 39,398 | $0 | 39,398 (Direct) | View |
2023-02-23 Exercise | 2023-02-27 8:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer | 7,906 | $0 | 31,011 (Direct) | View |
2023-02-18 Exercise | 2023-02-22 8:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer | 8,354 | $0 | 23,104 (Direct) | View |
2022-03-10 Option Award | 2022-03-14 4:15 pm | N/A 2032-03-09 | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 39,950 | $0 | 39,950 (Direct) | View |
2022-02-23 Exercise | 2022-02-25 7:09 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 7,906 | $0 | 46,954 (Direct) | View |
2022-02-18 Exercise | 2022-02-23 7:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 8,354 | $0 | 35,635 (Direct) | View |
2022-01-08 Exercise | 2022-01-11 8:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 13,093 | $0 | 29,327 (Direct) | View |
2021-02-23 Option Award | 2021-02-25 4:28 pm | N/A 2031-02-22 | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 42,433 | $0 | 42,433 (Direct) | View |
2021-02-18 Exercise | 2021-02-22 8:09 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 8,354 | $0 | 39,812 (Direct) | View |
2021-01-08 Exercise | 2021-01-12 7:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 13,092 | $0 | 30,577 (Direct) | View |
Ownership | 2020-10-28 4:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 0 | $0 | 209,698 (Direct) | View |